Followers | 581 |
Posts | 58320 |
Boards Moderated | 1 |
Alias Born | 09/02/2013 |
Tuesday, May 09, 2017 11:29:57 AM
On June 22, 2008 subsequent to the issuance of Patent No. 7,317,819, the Company intentionally allowed Patent No. 6,754,297 to expire for non-payment of required maintenance fees. Assuming continued payment of maintenance fees, U.S. Patent No. 7,317,819 expires no sooner than June 21, 2024; due to provisions in Title II of the Drug Price Competition and Patent Term Restoration Act, the patent term could be extended beyond this date
My post are for entertainment only ...I do not suggest or tell people when to buy or sell..... GLTA STACKER
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM